Landiolol Hydrochloride Patent Expiration

Landiolol Hydrochloride was first introduced by Aop Orphan Pharmaceuticals Ag in its drug Rapiblyk on Nov 22, 2024.


Landiolol Hydrochloride Patents

Given below is the list of patents protecting Landiolol Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Rapiblyk US10722516 Apr 25, 2034 Aop Orphan



Landiolol Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Landiolol Hydrochloride Generic API Manufacturers

Given below is the list of companies who have filed for Landiolol Hydrochloride generic, along with the locations of their manufacturing plants worldwide.